Quantification of Extracorporeal Fibrin Deposits in Haemodialysis with Minimal and Conventional Heparinization
暂无分享,去创建一个
H. Kalinowski | H. Pabst | G. Vogel | G. Buttermann | G. Blümel | Vogel Ge | Pabst Hw
[1] J. Porush,et al. Low-dose heparin in routine hemodialysis monitored by activated partial thromboplastin time. , 1979, Artificial organs.
[2] U. Binswanger,et al. Minimal intermittent heparinization during hemodialysis. , 1979, Nephron.
[3] G. Vogel,et al. [Heparin dosage in chronic hemodialysis (author's transl)]. , 1977, Medizinische Klinik.
[4] H. Kuhlmann. [Therapy of diabetic glomerulosclerosis (Kimmelstiel-Wilson syndrome)]. , 1976, Deutsche medizinische Wochenschrift.
[5] S. Wessler. Heparin as an antithrombotic agent. Low-dose prophylaxis. , 1976, JAMA.
[6] E. Cooke,et al. Letter: Monitoring during low-dose heparin prophylaxis. , 1976, The New England journal of medicine.
[7] M. Lie,et al. Heparin assay in plasma: a comparison of five clotting methods. , 1975, Thrombosis research.
[8] B. Bull,et al. Evaluation of tests used to monitor heparin therapy during extracorporeal circulation. , 1975, Anesthesiology.
[9] J. A. Hickman,et al. Behaviour of commercially prepared I-125 fibrinogen in metabolic studies. , 1975, Journal of clinical pathology.
[10] Godal Hc. Heparin assay methods for control of in vivo heparin effects. , 1975 .
[11] Lasch Hg,et al. Heparin therapy of diffuse intravascular coagulation (DIC). , 1975 .
[12] E. Lüscher,et al. Platelet Heparin-Neutralizing Factor (Platelet Factor 4) , 1975, Thrombosis and Haemostasis.
[13] J. Kiss. Chemistry of Heparin , 1975, Thrombosis and Haemostasis.
[14] V. Kakkar. Low Dose Heparin in the Prevention of Venons Thromboembolism , 1975, Thrombosis and Haemostasis.
[15] M. B. Zucker,et al. Effect of Heparin on Platelet Function , 1975, Thrombosis and Haemostasis.
[16] Jacques Lb. Letter: Standardisation of heparin for clinical use. , 1975 .
[17] R. Rosenberg. Actions and interactions of antithrombin and heparin. , 1975, The New England journal of medicine.
[18] H. Godal. Heparin Assay Methods for Control of in Vivo Heparin Effects , 1975, Thrombosis and Haemostasis.
[19] H. Lasch,et al. Heparin Therapy of Diffuse Intravascular Coagulation (DIC) , 1975, Thrombosis and Haemostasis.
[20] Y. Nosé. Die künstliche Niere: Ein Leitfaden für Ärzte, Krankenpflegepersonal und Patienten , 1974 .
[21] S. Wessler,et al. On the Antithrombotic Action of Heparin , 1974, Thrombosis and Haemostasis.
[22] H. Champion,et al. INDICATIONS FOR EARLY HÆMODIALYSIS IN MULTIPLE TRAUMA , 1974 .
[23] C. Mielke,et al. A simple method of heparin management during prolonged extracorporeal circulation. , 1974, The Annals of thoracic surgery.
[24] V. Heinze,et al. [Changes of plasma coagulatiion and blood platelet function in patients with kidney insufficiency and their modification through homodialysis, kidney transplantation and acetylsalicylic acid]. , 1974, Die Medizinische Welt.
[25] T. Cocke,et al. Regional vs "tight" heparinization in hemodialysis. , 1974, Proceedings of the Clinical Dialysis and Transplant Forum.
[26] H. Champion,et al. Indications for early haemodialysis in multiple trauma. , 1974, Lancet.
[27] J. Wallin,et al. Monitoring heparin therapy in hemodialysis. A report on the activated whole blood coagulation time tests. , 1973, JAMA.
[28] S. Epstein,et al. Statistical correlation and heparin sensitivity of activated partial thromboplastin time, whole blood coagulation time, and an automated coagulation time. , 1973, American journal of clinical pathology.
[29] E. Hiller. Überwachung der Heparintherapie bei thromboembolischen Erkrankungen , 1973 .
[30] S. Wessler,et al. Plasma heparin: a unique, practical, submicrogram-sensitive assay. , 1973, The Journal of laboratory and clinical medicine.
[31] S. Stock. STANDARDISATION OF HEPARIN FOR CLINICAL USE , 1972 .
[32] R. Piessens,et al. Metabolism and Distribution of Fibrinogen. I. FIBRINOGEN TURNOVER IN PHYSIOLOGICAL CONDITIONS IN HUMANS , 1972, British journal of haematology.
[33] K. Seiler,et al. Kontrolle der regionalen Heparinisierung der Hämodialyse mit einer vereinfachten Thrombinzeitbestimmung , 1972 .
[34] V. Kakkar. The diagnosis of deep vein thrombosis using the 125 I fibrinogen test. , 1972, Archives of surgery.
[35] W. Saggau,et al. [Changes of blood coagulation in patients with chronic kidney diseases and hemodialysis]. , 1972, Die Medizinische Welt.
[36] Ray Pk,et al. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy. , 1971 .
[37] T. A. Harper,et al. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy. , 1971, The Journal of laboratory and clinical medicine.
[38] H. Köstering,et al. [Anticoagulant treatment for avoiding the shunt-induced thrombosis in patients on hemodialysis]. , 1970, Medizinische Klinik.
[39] S. Wessler,et al. Heparin-accelerated inhibition of activated factor X by its natural plasma inhibitor. , 1970, Biochimica et biophysica acta.
[40] S. Zucker,et al. Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin. , 1969, The Journal of laboratory and clinical medicine.
[41] S. Wessler,et al. Investigation of the Apparent Thrombogenicity of Thrombin , 1968, Thrombosis and Haemostasis.
[42] C. R. Frisch,et al. Relationship of the partial thromboplastin time to the Lee-White coagulation time. , 1968, Technical bulletin of the Registry of Medical Technologists. American Society of Clinical Pathologists. Registry of Medical Technologists.
[43] M. Corn,et al. Control of Heparin Therapy With Activated Partial Thromboplastin Times , 1967 .
[44] S. Frye,et al. Use of the activated partial thromboplastin time in the control of heparin administration. , 1966, Clinical chemistry.
[45] H. Brögli. Der Mechanismus des sogenannten »Heparin-Rebound« nach extrakorporellem Kreislauf , 1965, Thrombosis and Haemostasis.
[46] D. Bittner,et al. The partial thromboplastin time (cephalin time) in anticoagulation therapy. , 1962, American journal of clinical pathology.
[47] L. Christensen. The turnover of plasma fibrinogen. , 2009, Acta medica Scandinavica.
[48] J. Graham,et al. Diagnosis and control of the hemophilioid states with the partial thromboplastin time (PTT) test. , 1958, American journal of clinical pathology.
[49] V. Richards,et al. Studies in regional heparinization. I. The use of simultaneous neutralization with protamine; preliminary studies. , 1956, The New England journal of medicine.
[50] P. White,et al. A CLINICAL STUDY OF THE COAGULATION TIME OF BLOOD , 1913 .